Page last updated: 2024-08-24

goralatide and Lung Neoplasms

goralatide has been researched along with Lung Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bignon, J; Fromes, Y; Katsoris, P; Kovacevic, M; Lallemand, JY; Lawrence, F; Liu, JM; Papadimitriou, E; Potier, P; Wdzieczak-Bakala, J1
Bogden, AE; Carde, P; de Paillette, ED; Frindel, E; Moreau, JP; Tubiana, M1

Other Studies

2 other study(ies) available for goralatide and Lung Neoplasms

ArticleYear
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
    Blood, 2003, Apr-15, Volume: 101, Issue:8

    Topics: Abdominal Wall; Adenocarcinoma; Allantois; Animals; Cell Differentiation; Cell Fusion; Cell Line, Transformed; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Collagen; Drug Combinations; Drug Implants; Endothelium, Vascular; Enzyme Activation; Enzyme Induction; Humans; Laminin; Lung Neoplasms; Matrix Metalloproteinase 1; Neovascularization, Physiologic; Oligopeptides; Proteoglycans; Rats; Rats, Wistar; Tumor Cells, Cultured; Umbilical Veins

2003
Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation.
    Annals of the New York Academy of Sciences, 1991, Volume: 628

    Topics: Animals; Body Weight; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line; Cyclophosphamide; Cytarabine; Female; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Immunologic Deficiency Syndromes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Transplantation, Heterologous

1991
chemdatabank.com